Trial Profile
The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud in Early Diffuse Systemic Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Diffuse scleroderma
- Focus Therapeutic Use
- Acronyms TAMER
- 10 Aug 2020 Status changed from active, no longer recruiting to completed.
- 01 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 13 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.